TY - JOUR
T1 - Relative prognostic value of self-reported adherence and plasma NNRTI/PI concentrations to predict virological rebound in patients initially responding to HAART
AU - Antinori, Andrea
AU - Cozzi-Lepri, Alessandro
AU - Ammassari, Adriana
AU - Trotta, Maria Paola
AU - Nauwelaers, David
AU - Hoetelmans, Richard
AU - Murri, Rita
AU - Melzi, Sara
AU - Narciso, Pasquale
AU - Nasta, Paola
AU - Zaccarelli, Mauro
AU - Santopadre, Paola
AU - Vecchiet, Jacopo
AU - Izzo, Crescenzo Maria
AU - D'Arminio Monforte, Antonella
PY - 2004/4
Y1 - 2004/4
N2 - We studied the predictive value of self-reported adherence and plasma drug concentrations on virological rebound to HAART. Among 238 participants in the AdICoNA study who had viral load ≤500 copies/ml, 42 (17.6%) experienced virological rebound by 96 weeks. Both self-reported non-adherence and sub-optimal concentration were independently associated with a higher risk of virological rebound.
AB - We studied the predictive value of self-reported adherence and plasma drug concentrations on virological rebound to HAART. Among 238 participants in the AdICoNA study who had viral load ≤500 copies/ml, 42 (17.6%) experienced virological rebound by 96 weeks. Both self-reported non-adherence and sub-optimal concentration were independently associated with a higher risk of virological rebound.
UR - http://www.scopus.com/inward/record.url?scp=2342441340&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2342441340&partnerID=8YFLogxK
M3 - Article
C2 - 15134192
AN - SCOPUS:2342441340
VL - 9
SP - 291
EP - 296
JO - Antiviral Therapy
JF - Antiviral Therapy
SN - 1359-6535
IS - 2
ER -